
    
      This is a non-randomized, single-case design of pharmacogenetic implementation in a mental
      health patient population of subjects taking antipsychotics and/or antidepressants.
      Retrospective and prospective data will be collected on all subjects before and after
      pharmacogenetic recommendations have been made. Retrospective data will be collected for the
      previous 12 months before pharmacogenetic recommendations are made and prospective data will
      be collected for 12 months after pharmacogenomic recommendations have been made.
    
  